(Q39658315)

13 September 2017

Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

13 September 2017

1 reference

1 reference

1 reference

4

Grace Lai-Hung Wong

1 reference

13 September 2017

9

Henry Lik-Yuen Chan

1 reference

13 September 2017

10

Vincent Wai-Sun Wong

1 reference

13 September 2017

8

Angel Mei-Ling Chim

1 reference

13 September 2017

7

Sally She-Ting Shu

1 reference

13 September 2017

Anthony Wing-Hung Chan

5

object named as

Anthony Wing-Hung Chan

1 reference

13 September 2017

Paul Cheung-Lung Choi

6

object named as

Paul Cheung-Lung Choi

1 reference

13 September 2017

Jonathan Chung-Fai Leung

1

1 reference

13 September 2017

Thomson Chi-Wang Loong

2

1 reference

13 September 2017

Jeremy Lok Wei

3

1 reference

13 September 2017

language of work or name

English

0 references

publication date

23 June 2016

1 reference

13 September 2017

1 reference

13 September 2017

65

1 reference

13 September 2017

1

1 reference

13 September 2017

54-64

1 reference

Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy.

13 September 2017

1 reference

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

21 January 2018

1 reference

Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.

21 January 2018

1 reference

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese.

21 January 2018

1 reference

Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy.

21 January 2018

1 reference

Nonalcoholic fatty liver disease in lean individuals in the United States

21 January 2018

1 reference

Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease?

21 January 2018

1 reference

Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.

21 January 2018

1 reference

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

21 January 2018

1 reference

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.

21 January 2018

1 reference

Lipoapoptosis induced by saturated free fatty acids stimulates monocyte migration: a novel role for Pannexin1 in liver cells

21 January 2018

1 reference

A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease

21 January 2018

1 reference

Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.

21 January 2018

1 reference

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

21 January 2018

1 reference

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

Association between patatin-like phospholipase domain containing 3 gene (PNPLA3) polymorphisms and nonalcoholic fatty liver disease: a HuGE review and meta-analysis

21 January 2018

1 reference

The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh

21 January 2018

1 reference

7 January 2021

Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers

1 reference

7 January 2021

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

1 reference

7 January 2021

Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in nonobese subjects

1 reference

7 January 2021

Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis

1 reference

7 January 2021

Association between anthropometric parameters and measurements of liver stiffness by transient elastography

1 reference

7 January 2021

Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity

1 reference

7 January 2021

PNPLA3gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome

1 reference

7 January 2021

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.28697

1 reference

13 September 2017

1 reference